Cyclosporine Nephrotoxicity
Authors: WILLIAM M. BENNETT
Journal: Annals of Internal Medicine (1983)

Editorials1 December 1983Cyclosporine NephrotoxicityWILLIAM M. BENNETT, M.D., JOSEPH P. PULLIAM, M.D.WILLIAM M. BENNETT, M.D., JOSEPH P. PULLIAM, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-99-6-851 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptCyclosporine is a potent new immunosuppressive agent that selectively inhibits T-cell function, allowing survival of allografts without myelosuppression. Its use should minimize the many adverse effects of long-term steroid therapy. Although the long-term effects of cyclosporine on renal allograft longevity are not well documented, enthusiastic reports in the medical literature and lay press have led to an unprecedented anticipation by prospective allograft recipients, particularly patients with chronic renal failure receiving long-term dialysis. However, these reports have not sufficiently emphasized the nephrotoxicity that frequently accompanies cyclosporine therapy.Cyclosporine is a lipophilic molecule with a molecular weight of 1202 daltons. When the...References1. BEVERIDGE T. Pharmacokinetics and metabolism of cyclosporin A. In: WHITE DJ, ed. Cyclosporin A: Proceedings of the International Symposium, Cambridge. Amsterdam: Elsevier Biomedical Publishers; 1982:35-44. Google Scholar2. KAHANRIEDNEWBERGER BMJ. Pharmacokinetics of cyclosporine in human renal transplantation. Transplant Proc. 1983;15:446-53. Google Scholar3. WHITE D. Cyclosporin A: clinical pharmacology and therapeutic potential. Drugs. 1982;24:322-34. CrossrefMedlineGoogle Scholar4. KAHAN B. Meeting Report: the First International Congress on Cyclosporine: Houston, Texas: May 16-19, 1983. Dial Transplant. 1983;12:620-30. Google Scholar5. VON WILLEBRANDHAYRY EP. Cyclosporin-A deposits in renal allografts. Lancet. 1983;2:189-92. CrossrefMedlineGoogle Scholar6. SIBLEYFERGUSONSUTHERLANDSIMMONSNAJARIAN RRDRJ. Morphology of cyclosporine nephrotoxicity and of acute rejection in cyclosporine-prednisone immUnosuppressed renal allograft recipients. Transplant Proc. 1983. (In press). Google Scholar7. WAGNERPICHYLMAYRWORIGEITKLEMPNAUERBUNZENDAHLLAUCHART ERKJHW. Differentiation between rejection and cyclosporin A nephrotoxicity by monitoring interstitial pressure in human renal allografts. Transplant Prod. 1983;15:489-92. Google Scholar8. HAMILTONCALNEEVANSHENDERSONTHIRUWHITE DRDRSD. The effect of long-term cyclosporin A on renal function [Letter]. Lancet. 1981;1:1218-9. CrossrefMedlineGoogle Scholar9. NAJARIANFERGUSONSUTHERLANDRYNASIEWICZSIMMONS JRDJR. A prospective trial of the efficacy of cyclosporine in renal transplantation at the University of Minnesota. Transplant Proc. 1983;15:438-41. Google Scholar10. HAMILTONEVANSTHIRU DDS. Toxicity of cyclosporin A in organ grafting. In: WHITE DJ, ed. Cyclosporin A: Proceedings of the International Symposium, Cambridge. Amsterdam: Elsevier Biomedical Publishers; 1982:393-411. Google Scholar11. VENKATACHALAM M. Pathology of acute renal failure. In: BRENNER B, STEIN J, eds. Chronic Renal Failure. New York: Churchill-Livingstone; 1981:79-107. Google Scholar12. FARNSWORTHHALLKIR WAN ABP. Pathology in renal transplant patients treated with cyclosporin A. Transplant Proc. 1983. (In press). Google Scholar13. MIHATSCHOLIVIERIMARBETTHIELHARDERZOLLINGER MWUGFH. Giant mitochondria in renal tubular cells and cyclosporin A [Letter]. Lancet. 1981;1:1162-3. CrossrefMedlineGoogle Scholar14. SHULMANSTRIKERDEEGKENNEDYSTORBTHOMAS HGHMRE. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med. 1981;305:1392-5. CrossrefMedlineGoogle Scholar15. LEITHNERSINZINGERPOHANKASCHWARZKRETSCHMERSYRE CHEMGG. Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation [Letter]. Lancet. 1982;1:1470. CrossrefMedlineGoogle Scholar16. GREENBERGEGELTHOMPSON AJM. Renal failure in heart transplant patients receiving cyclosporin A [Abstract]. Clin Res. 1983;31:429A. Google Scholar17. JossBARRETTKENDRALUCASDESAI DAJCS. Hypertension and convulsions in children receiving cyclosporin A [Letter]. Lancet. 1982;1:906. CrossrefMedlineGoogle Scholar18. ADUTURNEYMICHAELMCMASTER DJJP. Hyperkalemia in cyclosporin-treated renal allograft recipients. Lancet. 1983;2:370-2. CrossrefMedlineGoogle Scholar19. STILLERKEOWNSINCLAIRULAN CPNR. Immune responses and pharmacokinetics in the human renal allograft recipient treated with cyclosporin A. In: WHITE DJ, ed. Cyclosporin A: Proceedings of the International Symposium, Cambridge. Amsterdam: Elsevier Biomedical Publishers; 1982:379-86. Google Scholar20. KENNEDYDEEGSIEGELCROWLEYSTORBTHOMAS MHMJRE. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation. 1983;35:211-5. CrossrefMedlineGoogle Scholar21. FERGUSONSUTHERLANDSIMMONSNAJARIAN RDRJ. Ketoconazole, cyclosporin metabolism, and renal transplantation [Letter]. Lancet. 1982;2:882-3. CrossrefMedlineGoogle Scholar22. WHITINGTHOMSONBLAIRSIMPSON PAJJ. Experimental cyclosporin A nephrotoxicity. Br J Exp Pathol. 1982;63:88-94. MedlineGoogle Scholar23. RYFFEL B. Experimental toxicological studies with cyclosporin A. In: WHITE DJ, ed. Cyclosporin A: Proceedings of the International Symposium, Cambridge. Amsterdam: Elsevier Biomedical Publishers; 1982:45-75. Google Scholar24. BAXTERDUGGINWILLISHALLHORVATHTILLER CGNBJD. Cyclosporin A-induced increases in renin storage and release. Res Commun Chem Pathol Pharmacol. 1982;37:305-12. MedlineGoogle Scholar25. KIRWANBAXTERDUGGIN PCG. Giant mitchondria, renal transplant biopsy, and cyclosporin A [Letter]. Lancet. 1981;2:146. CrossrefMedlineGoogle Scholar26. CUNNINGHAMBURKEWHITINGSIMPSONWHEATLEY CMPJD. Ketoconazole, cyclosporin, and the kidney [Letter]. 1982;2:1464. Google Scholar27. SHIELHALLTILLER ABD. Australian trial of cyclosporin A in cadaveric donor transplantation. Transplant Proc. 1983. (In press). Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Oregon Health Sciences University; Portland, Oregon PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byImmunosuppressive Therapy and Immunomodulation in Stem Cell TransplantationDehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat modelEffects of vitamin D on drugs: Response and disposalMachine Learning for Identifying Medication-Associated Acute Kidney InjuryImmunosuppressive Therapy and Immunomodulation in Stem Cell TransplantationCyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantationA novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndromeGlomerular Diseases and Renal Transplantation: Pathogenic Pathways and Evolution of Therapeutic InterventionsThe epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in ratsSynergic development of pharmacokinetics and bioanalytical methods as support of pharmaceutical researchCyclosporine A kinetics in brain cell cultures and its potential of crossing the blood–brain barrierOral cyclosporine A in neonatal swines for transplantation studiesImpact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell TransplantationGeneric drugs: myths, facts, and limitationsCalcineurin Inhibitor NephrotoxicityTransplant HypertensionHepatic Injury following Reduced Intensity Unrelated Cord Blood Transplantation for Adult Patients with Hematological DiseasesGlomerulotubular Dysfunction and Acute Renal FailureCitrate Reverses Cyclosporin A-Induced Metabolic Acidosis and Bone Resorption in RatsEffect of Sirolimus Withdrawal in Patients with Deteriorating Renal FunctionCyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field NMR spectroscopy, HPLC-TOF/MS and chemometricsBioequivalence Behind the ScenesNitric Oxide Production Modulates Cyclosporin A-Induced Distal Renal Tubular Acidosis in the RatProphylaxis and treatment of gastrointestinal complications following transplantationChronic cyclosporine administration induces renal P-glycoprotein in ratsOPEN QUESTIONS ON BIOEQUIVALENCE: SOME PROBLEMS AND SOME SOLUTIONSSYNERGISTIC EFFECTS OF MYCOPHENOLATE MOFETIL AND SIROLIMUS IN PREVENTION OF ACUTE HEART, PANCREAS, AND KIDNEY ALLOGRAFT REJECTION AND IN REVERSAL OF ONGOING HEART ALLOGRAFT REJECTION IN THE RAT1,2STEROID-FREE IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION WITH ANTITHYMOCYTE GLOBULIN INDUCTION AND CYCLOSPORINE AND MYCOPHENOLATE MOFETIL MAINTENANCE THERAPYPosttransplant hypertensionAcute illness superimposed on chronic renal failureSympathoexcitatory Response to Cyclosporin A and Baroreflex ResettingTHE IMMUNOSUPPRESSIVE EFFECT OF RAPAMYCIN ON MOUSE SMALL BOWEL TRANSPLANTATION1Local Immunosuppression of Rat Cardiac, Liver, and Small Bowel AllograftsUrinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantationComparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression modelLung TransplantationThe effect of indomethacin on cyclosporin A- and its solvent-induced inhibition of endothelium-dependent relaxation and the drug-induced contraction of rabbit isolated arteriesCyclosporine-Induced Hypertension After TransplantationRenal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipientsDetermination of tacrolimus (FK 506) in whole blood using liquid chromatography and fluorescence detectionEarly Adoption of Cyclosporine and Recombinant Human Erythropoietin: Clinical, Economic, and Policy Issues With Emergence of High-Cost DrugsThe efficacy of systemic corticosteroids in sight-threatening retinal vasculitisNephrotoxic Effects of ImmunosuppressionImmunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate MofetilThe effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicityMechanisms of Action of Mycophenolic AcidGlomerular perfusion in renal allograft biopsiesIMMUNOSUPPRESSANTSEfficacy of Antihypertensive Medication in Orthotopic Heart Transplant Recipients and its Effect on Renal FunctionFenoldopam Reverses Cyclosporine-Induced Renal Vasoconstriction in Kidney Transplant RecipientsAcute effects of cyclosporin and cremophor EL on endothelial function and vascular smooth muscle in the isolated rat heartImmune Therapy for Autoimmune UveitisCyclosporine, Hypertension, and the KidneyCyclosporin and the gingival tissuesManagement of Drug Interactions With CyclosporineCyclosporin treatment does not impair the release of nitric oxide in human coronary arteries.A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantationEndothelium-derived relaxing and contracting factors: Perspectives in nephrologyImmunosuppressive drugs in immune and inflammatory ocular diseasePharmacology and pharmacokinetics of cyclosporineLymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide DepletionLong-term complications of cardiac transplantationDopexamine: studies in the general intensive care unit and after liver transplantationHLA-Identical Renal Transplants: Impact of Cyclosporine on Intermediate-Term Survival and Renal FunctionIsolated rat cardiomyocytes as an experimental model for studying acute cardiotoxicity of cyclosporin APreoperative Assessment for Lung TransplantationEvaluation of Kidney Function in Renal Transplant Patients Receiving Long-Term CyclosporineCyclosporine-induced changes in glomerular filtration rate and urea excretionNephrotoxicity of Common Drugs Used by UrologistsEicosanoids and Acute Renal FailureEffect of cyclosporin A on renal function and kidney growth in the uninephrectomized ratThe Effect of Cyclosporine on the Use of Hospital Resources for Kidney TransplantationDonor specific transfusions or cyclosporine for related-donor kidney transplantation?Acquired Immune Tolerance to Cadaveric Renal AllograftsBeyond 1 Year After Liver TransplantationHealth impact of renal disease due to nephrotoxicityAbnormalities in arachidonic acid metabolites in nephrotoxic glomerular injurySandimmun®/An Appraisal of Drug InteractionsDrug Induced Renal Effects of Cyclosporine, Aminoglycoside Antibiotics and Lithium: Extrapolation of Animal Data to ManThe Effects of Cyclosporin a on the Urine Excretion of Specific Proteins in HumansChanges in immunological parameters after conversion from cyclosporine A to azathioprine in renal transplant recipientsPeriradicular healing in a renal transplant patientImpact on energy metabolism of quantitative and functional cyclosporine-induced damage of kidney mitochondriaNoninvasive Renal Diagnostic StudiesIncreased Cyclosporine Blood Concentrations Due to Verapamil AdministrationIntensive care of the cardiac transplant recipientIncreased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicityHistological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.Myasthenia gravis treated with ciclosporinCyclosporine Nephrotoxicity Is Minimized by Adjusting Dosage on the Basis of Drug Concentration in BloodStrategies for Specific Immunosuppression in Vitro with CyclosporineCyclosporine increases calcium in kidney medullaNonsteroidal Immunosuppressive Therapy in Polymyositis and DermatomyositisAcute Renal Failure and Dialysis in Cancer PatientsMononuclear cells infiltrating kidney allografts in the absence of rejection Effect of conversion from cyclosporin to azathioprine therapyThe covalent binding of cyclosporin a to rat liver macromolecules in vivo and in vitro: The role of cytochrome P-450Combined steroid-cyclosporin treatment of chronic autoimmune diseasesThe Plasma Creatinine Concentration Is Not an Accurate Reflection of the Glomerular Filtration Rate in Stable Renal Transplant Patients Receiving CyclosporineSuppression of plasma renin activity by cyclosporineEffects of renal impairment on liver transplantationCyclosporine augments reactivity of isolated blood vesselsThe influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicityRenal Transplant RejectionAcute Renal Failure and Toxic NephropathyThe Medical Management of Renal Transplant PatientsThe Measurement of Kidney-Derived Immunologically Reactive Material in Urine and Plasma for Studying Renal IntegrityThe prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamineEarly Renal Pathophysiology in an Acute Model of Cyclosporine Nephrotoxicity in RatsCyclosporine: Structure, Pharmacokinetics, and Therapeutic Drug MonitoringThe rate of spread and population increase of forest trees during the postglacialCyclosporine nephrotoxicityCeftazidime does not enhance cyclosporin-a nephrotoxicity in febrile bone marrow transplantation patientsCeftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patientsSide effects of cyclosporin A treatment in patients with rheumatoid arthritisRenal Histopathologic Alterations in Patients Treated with Cyclosporine for UveitisHypertension and CyclosporineJACQUES J. SENNESAEL, M.D., ALAIN G. DUPONT, M.D., DIERIK L. VERBEELEN, M.D., L. VAN HAELST, M.D., Ph.D., LEENDERT C. PAUL, M.D., Ph.D.Cyclosporine: A review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problemsCyclosporin and renal graft histology.Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantationEffect of cyclosporine administration on renal hemodynamics in conscious ratsDIFFERENTIATION BETWEEN ALLOGRAFT REJECTION AND CYCLOSPORIN NEPHROTOXICITY IN RENAL-TRANSPLANT RECIPIENTSCyclosporine in Cardiac TransplantationCiclosporin in Autoimmune Diseases — Side Effects (with Emphasis on Renal Dysfunction) and Recommendations for UseINTERSTITIAL FIBROSIS IN RENAL ALLOGRAFTS IN PATIENTS TREATED WITH CYCLOSPORINCyclosporine-Associated Chronic NephropathyMechanisms of Drug NephrotoxicityNephrologie III 1 December 1983Volume 99, Issue 6Page: 851-854KeywordsImmunosuppressivesMedical dialysisRenal failureSteroid therapy Issue Published: 1 December 1983 PDF downloadLoading ...